Merck's Singulair Forecast to Decline $1 Billion in 2013...

Merck being hit hard by generic versions of its respiratory therapeutic Singulair, which has generated $44+ billion since its 1998 launch.

The story here:

seekingalpha.com/article/1521632 … icle_title